Results for cellularity translation from English to Estonian

English

Translate

cellularity

Translate

Estonian

Translate
Translate

Instantly translate texts, documents and voice with Lara

Translate now

Human contributions

From professional translators, enterprises, web pages and freely available translation repositories.

Add a translation

English

Estonian

Info

English

bone marrow cellularity

Estonian

luuüdi rakulisus

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

if the bone marrow cellularity is > 50 %, no dose adjustments should be made.

Estonian

kui luuüdi rakulisus on > 50%, ei tohi annust kohandada.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Warning: Contains invisible HTML formatting

English

in rats decreased cellularity of the bone marrow and thymic atrophy were observed only in the carcinogenicity study.

Estonian

rottidel esines ainult kantserogeensuse uuringus luuüdi tsellulaarsuse vähenemist ja tüümuse atroofiat.

Last Update: 2017-04-26
Usage Frequency: 4
Quality:

English

however, if recovery has not been achieved within 14 days, bone marrow cellularity should be determined.

Estonian

kui taastumist ei ole 14 päeva jooksul saavutatud, tuleb määrata luuüdi rakulisus.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

if bone marrow cellularity is ≤ 50%, treatment should be delayed and the dose reduced according to the following table:

Estonian

kui luuüdi rakuline tihedus on ≤ 50%, tuleb ravi edasi lükata ja vähendada annust vastavalt järgmisele tabelile:

Last Update: 2011-10-23
Usage Frequency: 1
Quality:

Warning: This alignment may be wrong.
Please delete it you feel so.

English

in a study in dogs in which trametinib and dabrafenib were given in combination for 4 weeks, signs of gastrointestinal toxicity and decreased lymphoid cellularity of the thymus were observed at lower exposures than in dogs given trametinib alone.

Estonian

uuringus koertel, milles kasutati 4 nädala jooksul tramentiniibi ja dabrafeniibi kombinatsiooni, täheldati madalate plasmakontsentratsioonide juures seedetrakti toksilisust ja lümfikoe vähenemist tüümuses, võrreldes trametiniibi monoteraapiaga koertel.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

in a study in dogs in which trametinib and dabrafenib were given in combination for 4 weeks, signs of gastro-intestinal toxicity and decreased lymphoid cellularity of the thymus were observed at lower exposures than in dogs given trametinib alone.

Estonian

uuringus koertel, milles kasutati 4 nädala jooksul tramentiniibi ja dabrafeniibi kombinatsiooni, täheldati madalate plasmakontsentratioonide juures seedetrakti toksilisust ja lümfikoe vähenemist tüümuses, võrreldes trameteniibi monoteraapiaga koertel.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

findings of note included treatment related adverse reactions of the liver in rats (characterized by centrilobular congestion, abnormal cell division, hepatocellular necrosis and pericentral vein/interlobular fibrosis) which may be related to circulatory disturbances and changes indicative of increased haematopoiesis (high reticulocyte ratio and/or platelet count, increased cellularity of the haematopoietic cells in the femoral and sternal bone marrow, and/or extramedullary haematopoiesis in the liver and spleen).

Estonian

tähelepanu väärivate leidude hulka kuulusid raviga seotud kõrvaltoimed rottide maksas (mida iseloomustavad tsentriloburaalne pais, rakkude ebanormaalne jagunemine, hepatotsellulaarne nekroos ja peritsentraalse veeni / interloobiumi fibroos), mis võivad olla seotud tsirkulatoorsete häiretega ja suurenenud vereloomet näitavate muutustega (suur retikulotsüütide suhe ja/või suur trombotsüütide arv, vereloomerakkude tsellulaarsuse suurenemine reieluu ja rinnaku luuüdi materjalis ja/või ekstramedullaarne vereloome maksas ja põrnas).

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Get a better translation with
8,941,008,734 human contributions

Users are now asking for help:



We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. Learn more. OK